BackPhoenix Biotech Acquisition Overview

Phoenix Biotech Acquisition Operating Income

Operating Income for PBAX.

Quarterly Operating Income

$-4845728.00
↓ 2.12% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-18358346.00
↓ 36.68% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin